Clinical Trials Directory

Trials / Recruiting

RecruitingNCT01789229

Establishment of a Tumor Bank for Tissue Samples

Establishment of a Tissue Sample Bank in the Field of Gynaecological Oncology

Status
Recruiting
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Establishment of a tumor bank, consisting of tissue samples of tumor patients (benign and malign tumors) and healthy people as controls. The tissue samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tissue tumor bank. This tumor bank for tissue samples, together with our tumorbank for blood samples (NCT01763125) combined constitute the entity "Tumorbank".

Detailed description

Recent progress in diagnosis and therapy of cancer diseases can be ascribed mainly to translational research. The relevance of "translational oncology" will only increase in the future -"From bench to bedside" - the swift implementation of new science research results in clinical studies in order to expedite progress in clinical cancer therapy for the benefit of the patient. Its almost a matter of course in the medical science today to collect biological samples together with clinical information thereby creating the foundation for future excellent fundamental research. The aim of this tumor bank is to consist of biological samples (together with a blood bank - see NCT01763125) and isolates of tumor patients and healthy people as controls. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank. The content of the tumor bank can provide essential material for current and future research (e.g. analyses of prognostic or predictive tumor markers; genetically analysis (polymorphism, mutation, hypermethylation; verification and characterisation of disseminated tumor cells).

Conditions

Interventions

TypeNameDescription
OTHERTumor tissue collectionTissue sample is collected during therapeutic intervention by a medical doctor/surgeon. Frozen tissue sections are first transferred to Dept.of Pathology. Pathologist samples required tissue to obtain enough evidence for analysis/diagnosis. Rest tumor material with or without malignant cells is tranferred to the lab for Molecular Oncology of Prof.Zeillinger.
OTHERSampling of ascites and pleural effusionSamples of malignant ascites and/or malignant pleural effusion is only collected during therapeutic intervention from patients at inpatient care.
OTHERCollecting urine samplesPatient is asked to give a urine sample. Urine is collected in urine beaker.
OTHERCollecting saliva sampleSaliva sample is collected by spatula from the mouth cavity of the patient.
OTHERCollecting sputumPatient is asked to produce sputum into a 50ml lab tube.
OTHERCollecting stool samplesStool samples are collected prior to bowel preparation for colonoscopy. Device for sampling is provided to the patient.
OTHERLavage/IrrigationIrrigation liquid is collected during routine therapeutic or diagnostic procedure, e.g. lavage of the uterine cavity and fallopian tubes of women scheduled for surgery.

Timeline

Start date
2003-09-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2013-02-12
Last updated
2023-03-23

Locations

3 sites across 3 countries: Austria, Belgium, Germany

Source: ClinicalTrials.gov record NCT01789229. Inclusion in this directory is not an endorsement.